← Back

Crystal Growth & Energy Equipment Co. Ltd. A

Crystal Growth & Energy Equipment Co., Ltd. is a Chinese company engaged in the research, development, production, and sales of crystal growth equipment. Its product lineup includes semiconductor-grade single crystal silicon furnaces, photovoltaic-grade monocrystalline silicon furnaces and control systems, and silicon carbide semiconductor equipment such as single crystal and epitaxial furnaces and thermal consumables. The company also offers crystal processing equipment, including multi-wire cutting machines, fully automatic wafer thinning machines, single-sided polishing machines, and silicon wafer edge polishing systems, as well as other crystal devices like induction heating silicon carbide powder synthesis systems, resistance heating silicon carbide powder systems, aluminum nitride crystal growth equipment, polycrystalline silicon ingot furnaces, silicon carbide coating equipment, HVPE single crystal growth equipment, high-pressure furnace general platforms, and stone multi-wire cutting equipment. Founded in 2012, it is based in Nanjing, China.

Price · split & dividend adjusted
News & notes moving 688478.CG
China
688478.CG▼

Jingsheng Shares Receives Warning Letter from Jiangsu Securities Regulatory Bureau over Accounting Error Corrections

Jingsheng Shares disclosed on the evening of September 24 that the company, its chairman and general manager Li Hui, and former chief financial officer Wu Chunsheng received an administrative regulatory decision from the Jiangsu Securities Regulatory Bureau. Due to inaccurate information disclosure caused by corrections of prior accounting errors, the company was given a warning letter as an administrative regulatory measure and the matter was recorded in the securities and futures market integrity archive. The Jiangsu Securities Regulatory Bureau determined that the company's information disclosure in the first quarter, half-year, and third quarter reports of 2025 was inaccurate, violating the provisions of Article 3, Paragraph 1 of the Measures for the Administration of Information Disclosure by Listed Companies. Li Hui and Wu Chunsheng failed to perform their duties diligently and bear primary responsibility for the above violations. The decision requires the company to strengthen internal controls and improve financial accounting standards, and all directors and senior management should enhance their study of securities laws and regulations, and submit a written report to the Jiangsu Securities Regulatory Bureau within 10 working days from the date of receiving the decision. Jingsheng Shares is a supplier of semiconductor specialized equipment. In the first half of 2026, it achieved operating revenue of 40.6483 million yuan, a year-on-year decrease of 41.72 percent, and a net loss attributable to shareholders of the listed company of 11.7651 million yuan, with the loss expanding by 100.04 percent year-on-year. The company stated that this administrative regulatory measure will not affect its normal business management activities, and reminded investors to pay attention to investment risks.
688478.CG · Regulation · Negative Jingsheng Shares (Crystal Growth & Energy Equipment) received a warning letter from the Jiangsu Securities Regulatory Bureau over inaccurate disclosure from accounting error corrections, with the matter recorded in the integrity archive.
Read original ↗
每日经济新闻·12dRead more →
China
688478.CG▼3

Jingsheng Shares Terminates Major Asset Restructuring and Withdraws Application Documents

Jingsheng Shares announced on August 30 that it has decided to terminate the issuance of shares and payment of cash to purchase assets, the related fundraising, and the connected transaction, and to withdraw the application documents. The restructuring was initiated in August 2025 and was called off after about a year. The company had originally planned to acquire 100 percent of Beijing Weizhun Intelligent Technology Co., Ltd., but due to changes in the overall market environment compared with the early stage of the transaction planning, and after prudent consideration and friendly consultation with the transaction parties, it decided to terminate the deal. The company pledged not to plan any major asset restructuring for at least one month from the date of the termination announcement, and plans to hold an investor briefing on September 1. The 2026 semi-annual report disclosed on the same day shows that the company achieved operating revenue of 40.6483 million yuan in the first half of the year, down 41.72 percent year on year. Net profit attributable to shareholders of the listed company was negative 11.7651 million yuan, down 100.04 percent year on year. Despite the earnings pressure, the company maintained high research and development investment, with first-half R&D expenses of 21.0355 million yuan, accounting for 51.75 percent of operating revenue.
688478.CG · Capital · Negative Jingsheng Shares terminated its major asset restructuring to acquire Beijing Weizhun and withdrew application documents, and reported H1 revenue down 41.72% with net loss widening 100.04%.
北京为准智能科技股份有限公司 · Capital · Neutral Beijing Weizhun was the acquisition target whose 100% stake purchase was terminated due to changed market environment, leaving its deal outcome unclear.
Read original ↗
每日经济新闻·37dRead more →
China
688478.CG▼2

Jingsheng Shares' 2026 Interim Report Shows Net Loss Widening to 11.7651 Million Yuan

Jingsheng Shares released its 2026 interim report, with total operating revenue of 40.6483 million yuan, down 41.72% year-on-year, and net profit attributable to the parent company of negative 11.7651 million yuan, a wider loss than the same period last year. Net cash flow from operating activities was negative 17.5957 million yuan, the asset-liability ratio rose to 16.56%, gross margin was 24.56%, return on equity was negative 0.78%, and diluted earnings per share was negative 0.09 yuan. The company had 14,400 shareholders, and the top ten shareholders held 52.88% of total share capital.
688478.CG · Capital · Negative Net loss widened to 11.7651 million yuan with revenue down 41.72%.
Read original ↗
Jiemian·39dRead more →
ChinaParaguay
688478.CG▲

Tiantong Corporation boosts investment in new soft magnetic materials, Zhonghong Medical net profit surges 2662%

Tiantong Corporation plans to invest 434 million yuan through a wholly-owned subsidiary to build an intelligent manufacturing project with an annual output of 14,600 tonnes of high-end soft magnetic new materials, with a construction period of about 36 months. Zhonghong Medical's net profit attributable to the parent company in the first half of the year surged 2662.38% year-on-year to 159 million yuan. In addition, several companies released half-year reports, with Hangzhou Cable, Yahua Group, and Yongtai Technology all posting substantial net profit growth. Jingsheng Co.'s self-developed large-size CVD SiC chemical vapour deposition coating complete equipment has passed factory inspection and been delivered to customers. Sino Medical's H-share issuance is being filed with the China Securities Regulatory Commission and is expected to be completed in the first quarter of next year; its HT Supreme drug-eluting stent system has been approved in Paraguay. Institutional seats made net purchases of 656 million yuan in Hengtong Optic-Electric and 168 million yuan in Yangtze Optical Fibre and Cable. Wanxun Automation has made progress in its domestic and overseas semiconductor business layout, and Shandong Haode and Anhui Kaize, controlled by Intco Medical, delivered excellent second-quarter profits.
300981.CS · Capital · Positive Zhonghong Medical's net profit surged 2662.38% year-on-year to 159 million yuan
002497.CS · Capital · Positive Yahua Group posted substantial net profit growth in half-year report
002326.CS · Capital · Positive Yongtai Technology posted substantial net profit growth in half-year report
300677.CS · Capital · Positive Intco Medical's controlled subsidiaries delivered excellent second-quarter profits
603618.CG · Capital · Positive Hangzhou Cable posted substantial net profit growth in half-year report
688108.CG · Capital · Positive Sino Medical's H-share issuance filed and HT Supreme stent approved in Paraguay
Read original ↗
上海证券报·41dRead more →